[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370503-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370503-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","therapeutic-potential-of-translational-readthrough-at-disease-associated-premature-termination-codons-from-tumor-suppressor-genes","Therapeutic Potential of Translational Readthrough at Disease-Associated Premature Termination Codons from Tumor Suppressor Genes","","Tumor suppressor genes are often disrupted by mutations that introduce premature termination codons (PTC) within protein-coding sequences, contributing to pathogenicity in sporadic cancers and hereditary cancer predisposition syndromes. These mutations can yield C-terminally truncated proteins with impaired stability and function and can also reduce mRNA abundance via nonsense-mediated mRNA decay. Pharmacologically induced translational readthrough can suppress PTC, restoring full-length tumor suppressor protein biosynthesis and stabilizing PTC-targeted transcripts. This review summarizes recent advances and evaluates therapeutic potential across hereditary syndromic patient groups.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/therapeutic-potential-of-translational-readthrough-at-disease-associated-premature-termination-codons-from-tumor-suppressor-genes/370503/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/therapeutic-potential-of-translational-readthrough-at-disease-associated-premature-termination-codons-from-tumor-suppressor-genes/370503.png","ImageObject",300,407,{"name":42,"@type":43},"\tCallum ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why do premature termination codons (PTC) in tumor suppressor genes cause high pathogenic impact?","Question",{"text":63,"@type":64},"They can generate C-terminal truncated proteins with altered stability and function, and PTC-containing transcripts can trigger transcript degradation through nonsense-mediated mRNA decay.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does translational readthrough counteract disease-associated PTC mutations?",{"text":68,"@type":64},"Pharmacologically induced translational readthrough misreads the PTC, extends translation to the natural termination codon, and restores production of full-length tumor suppressor proteins while stabilizing the targeted mRNA.",{"name":70,"@type":61,"acceptedAnswer":71},"What determines whether PTC-targeted mRNA is sensitive to nonsense-mediated mRNA decay (NMD)?",{"text":72,"@type":64},"NMD sensitivity varies based on intrinsic and extrinsic molecular and cellular factors, including the position of the PTC relative to exon-exon junctions and whether it resides in the last coding exon.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370503,1790664822,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","IUBMB Life  \nSPECIAL ISSUE ARTICLE  OPEN ACCESS   \nTherapeutic Potential of Translational Readthrough at Disease-Associated Premature Termination Codons From Tumor Suppressor Genes  \nLeire Torices1  | Caroline E. Nunes-Xavier1,2,3  | Rafael Pulido1,2,4   \n1Biobizkaia Health Research Institute, Barakaldo, Spain | 2Centro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, ISCIII, Spain | 3Institute for Cancer Research, Oslo University Hospital, Oslo, Norway | 4Ikerbasque, The Basque Foundation for Science, Bilbao, Spain Correspondence: Rafael Pulido ([rpulidomurillo@gmail.com](rpulidomurillo@gmail.com); [rafael.pulidomurillo@bio-bizkaia.eus](rafael.pulidomurillo@bio-bizkaia.eus))  \nReceived: 3 February 2025 | Revised: 27 March 2025 | Accepted: 14 April 2025  \nFunding: This work was partially supported by CIBERER and Instituto de Salud Carlos III through the project PI23/00959 (Spain and co-funded by European Union). LT has been the recipient of a predoctoral fellowship from Asociación Española Contra el Cáncer (AECC, Junta Provincial de Bizkaia, Spain). CEN-X is the recipient of a Miguel Servet Research Contract from Instituto de Salud Carlos III (grant number CP20/00008, Spain and co-funded by European Union). RP is funded by Ikerbasque, The Basque Foundation for Science, Spain.  \nABSTRACT  \nTumor suppressor genes are frequently targeted by mutations introducing premature termination codons (PTC) in the protein coding sequence, both in sporadic cancers and in the germline of patients with cancer predisposition syndromes. These mutations have a high pathogenic impact since they generate C-terminal truncated proteins with altered stability and function. In addition, PTC mutations trigger transcript degradation by nonsense-mediated mRNA decay. Suppression of PTC by translational readthrough restores protein biosynthesis and stabilizes the PTC-targeted mRNA, making a suitable therapeutic approach thereconstitution of active full-length tumor suppressor proteins by pharmacologically-induced translational readthrough. Here, wereview the recent advances in small molecule pharmacological induction of translational readthrough of disease-associated PTC from tumor suppressor genes, and discuss the therapeutic potential of translational readthrough in specific groups of patients with hereditary syndromic cancers.  \n1 | Premature Termination Codons (PTC), Translation Termination, and Translational Readthrough  \nA large number of genetic disorders are caused by the introduction ofa premature termination codon (PTC) in the protein coding sequence, directly caused by in-frame nonsense single-nucleotide substitutions or indirectly by frameshift small nucleotide insertions or deletions [1–3]. Mutations causing PTC are usually disruptive due to the generation of aberrant C-terminal truncated proteoforms, which likely display decreased protein stability and altered function. PTC may also cause nonsense mutation-dependent reinitiation of translation when ATG codons are present downstream  \nin the vicinity of the PTC [4–6]. In addition, transcripts containing PTC are subjected to nonsense-mediated mRNA decay (NMD), amRNA surveillance mechanism which leads to mRNA degradation under conditions of premature translation termination [7, 8]. In many genetic diseases, as well as in the case of tumor suppressors and cancer, an enrichment is found in pathogenic PTC that trigger NMD [9, 10], although many mRNA harboring PTC remain NMD-insensitive. NMD sensitivity of PTC-targeted mRNA is variable and depends on intrinsic and extrinsic molecular and cellular factors. For instance, mRNA with PTC located \u003C 50–55 nucleotides upstream of an exon-exon junction, or with PTC located in the last coding exon, escape NMD degradation [11–13]. A recent prediction based on a comprehensive in silico analysis  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution i","cbCaiv6kzvQIysif","https://ap.wps.com/l/cbCaiv6kzvQIysif","pdf",1736293,15,"English","# Premature Termination Codons (PTC), Translation Termination, and Translational Readthrough\n## Clinical and molecular impact of PTC\n## Nonsense-mediated mRNA decay and variable NMD sensitivity\n## Translational readthrough as a therapeutic strategy\n# Therapeutic potential of translational readthrough in hereditary syndromic cancers","[{\"question\":\"Why do premature termination codons (PTC) in tumor suppressor genes cause high pathogenic impact?\",\"answer\":\"They can generate C-terminal truncated proteins with altered stability and function, and PTC-containing transcripts can trigger transcript degradation through nonsense-mediated mRNA decay.\"},{\"question\":\"How does translational readthrough counteract disease-associated PTC mutations?\",\"answer\":\"Pharmacologically induced translational readthrough misreads the PTC, extends translation to the natural termination codon, and restores production of full-length tumor suppressor proteins while stabilizing the targeted mRNA.\"},{\"question\":\"What determines whether PTC-targeted mRNA is sensitive to nonsense-mediated mRNA decay (NMD)?\",\"answer\":\"NMD sensitivity varies based on intrinsic and extrinsic molecular and cellular factors, including the position of the PTC relative to exon-exon junctions and whether it resides in the last coding exon.\"}]","Therapeutic Potential of Translational Readthrough at Disease-Associated Premature Termination Codons from Tumor Suppressor Genes | PDF",1790188865,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b049b72d766ac15913acef597df1de8e.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4928060c7367021dd617492d4f9be30.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ee3008c6af0369634863d52e8c14075.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dea7d9b3f046c995fa35a5d9c12878e3.webp",980,1287]